PATH vs SSKN
Uipath Inc (PATH) versus STRATA Skin Sciences Inc (SSKN) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
STRATA Skin Sciences Inc (SSKN) is a medical devices company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported SSKN revenue for 2024-12-31 was $33.6M. Net income was -$10.1M. Revenue was up 0.6% from 2023-12-31 to 2024-12-31. SSKN currently screens at market cap $877.3K.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. SSKN currently screens at market cap $877.3K.
Not investment advice. Open the PATH and SSKN stock pages for the full models.
Not investment advice.